YS Biopharma Co. Ltd.

NASDAQ: YS · Real-Time Price · USD
1.02
0.09 (9.68%)
At close: May 24, 2024, 10:00 PM

YS Biopharma Cash Flow Statement

Financials in CNY. Fiscal year is undefined.
Fiscal Year Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Net Income
n/a 40.74M 52.27M 52.27M 52.27M 11.52M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a
Other Working Capital
n/a 252.53K 2.3M 2.3M 2.3M 2.05M
Other Non-Cash Items
n/a -44.89M -59.15M -59.15M -59.15M -14.26M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a 252.53K 2.3M 2.3M 2.3M 2.05M
Operating Cash Flow
n/a -3.89M -4.58M -4.58M -4.58M -693.96K
Capital Expenditures
n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a
Financial Cash Flow
n/a n/a n/a n/a n/a n/a
Net Cash Flow
n/a -3.9M -4.6M -4.6M -4.6M -698.7K
Free Cash Flow
n/a -3.89M -4.58M -4.58M -4.58M -693.96K